Literature DB >> 7507127

Suppression of antibody responses to ricin A chain (RTA) by monoclonal anti-RTA antibodies.

V S Byers1, E B Austin, J A Clegg, G Denton, B Gunn, D Hooi, F Hudecz, M R Price, R W Baldwin.   

Abstract

Balb/c mice treated with an immunotoxin constructed by conjugation of murine monoclonal antibody 791T/36 via a disulfide linker to ricin A chain generate a pronounced antibody response to peptide epitopes on ricin A chain. Monoclonal anti-RTA antibodies which recognize peptide epitopes have been developed and these have been used to down-regulate anti-RTA antibody responses in 791T/36-RTA immunotoxin-treated Balb/c mice. Of the five MAB tests, two (608/7 and 596/134) proved most effective, inhibiting anti-RTA antibody formation by up to 73%. MAB treatment was effective when initiated up to 3 days after immunotoxin treatment. Pharmacokinetic studies with 791T/36-RTA have shown that the immunotoxin is rapidly eliminated from the circulation, with no more than 4% remaining in blood after 24 hr. It is proposed that the down-regulation of anti-RTA antibodies is effected by MAB interfering with antigen processing.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 7507127     DOI: 10.1007/bf00920016

Source DB:  PubMed          Journal:  J Clin Immunol        ISSN: 0271-9142            Impact factor:   8.317


  23 in total

Review 1.  Targeted kill: from umbrellas to monoclonal antibodies.

Authors:  V S Byers; R W Baldwin
Journal:  J Clin Immunol       Date:  1992-11       Impact factor: 8.317

Review 2.  Signals involved in germinal center reactions.

Authors:  M H Kosco; D Gray
Journal:  Immunol Rev       Date:  1992-04       Impact factor: 12.988

Review 3.  Immunotoxins containing ricin or its A chain.

Authors:  E S Vitetta; P E Thorpe
Journal:  Semin Cell Biol       Date:  1991-02

4.  Regulation of antibody responses by antibody towards the immunogen.

Authors:  R Taylor
Journal:  Immunol Today       Date:  1982-02

5.  Phase I evaluation of an anti-breast carcinoma monoclonal antibody 260F9-recombinant ricin A chain immunoconjugate.

Authors:  L M Weiner; J O'Dwyer; J Kitson; R L Comis; A E Frankel; R J Bauer; M S Konrad; E S Groves
Journal:  Cancer Res       Date:  1989-07-15       Impact factor: 12.701

6.  Idiotype regulation of the anti-bovine serum albumin response. I. Generation of an idiotype-specific Lyt-1-2+ suppressor T cell.

Authors:  N K Eddy; R J Apple; J G Michael
Journal:  J Immunol       Date:  1987-03-15       Impact factor: 5.422

7.  The three-dimensional structure of ricin at 2.8 A.

Authors:  W Montfort; J E Villafranca; A F Monzingo; S R Ernst; B Katzin; E Rutenber; N H Xuong; R Hamlin; J D Robertus
Journal:  J Biol Chem       Date:  1987-04-15       Impact factor: 5.157

8.  Biodistribution of ricin toxin A chain-monoclonal antibody 791T/36 immunotoxin and influence of hepatic blocking agents.

Authors:  V S Byers; M V Pimm; I Z Pawluczyk; H M Lee; P J Scannon; R W Baldwin
Journal:  Cancer Res       Date:  1987-10-15       Impact factor: 12.701

9.  Mapping of monoclonal antibody-defined epitopes associated with carcinoembryonic antigen, CEA.

Authors:  M R Price; S Edwards; E Jacobs; I Z Pawluczyk; V S Byers; R W Baldwin
Journal:  Cancer Immunol Immunother       Date:  1987       Impact factor: 6.968

10.  Tumour localisation with a radioactively labelled reshaped human monoclonal antibody.

Authors:  V Hird; M Verhoeyen; R A Badley; D Price; D Snook; C Kosmas; C Gooden; A Bamias; C Meares; J P Lavender
Journal:  Br J Cancer       Date:  1991-11       Impact factor: 7.640

View more
  1 in total

1.  Identification of ricin A-chain HLA class II-restricted epitopes by human T-cell clones.

Authors:  M Tommasi; D Castelletti; M Pasti; G Fracasso; I Lorenzetti; S Sartoris; C Pera; G B Ferrara; G Tridente; M Colombatti
Journal:  Clin Exp Immunol       Date:  2001-09       Impact factor: 4.330

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.